Avricore Health's HealthTab expands globally with UK feasibility study

Avricore Health CEO Hector Bremner tells Proactive's Stephen Gunnion that HealthTab has been selected for a UK-based feasibility study, marking an important international expansion.

Avricore Health has achieved success in Canada with HealthTab, the company's leading pharmacy-based platform for testing and health data management. Now, in partnership with Barts Hart Centre and HEART UK, the platform will be used to support NHS England's efforts to enhance community pharmacy-driven care for cardiovascular disease.

The success of the NHS's Health Check program, which conducted over a million opportunistic blood pressure checks, revealed the need for advanced screening methods.

Bremner emphasized the increasing role of community pharmacies in global healthcare systems, offering on-demand care beyond emergency rooms. The feasibility study will initially focus on five locations in London, with plans to rapidly scale up to 50 and beyond.

Avricore Health envisions HealthTab as a global solution, with consistent demand across markets, and the UK's supportive pharmacy infrastructure and population size make it an ideal starting point.

Bremner expressed optimism about HealthTab's potential to revolutionize healthcare delivery internationally.

Contact Details

Proactive Studio

+1 347-449-0879

na-editorial@proactiveinvestors.com